Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from 4DMedical Ltd ( (AU:4DX) ) is now available.
4DMedical Ltd announced the issuance of 3,270,165 unquoted securities, specifically options expiring on February 29, 2028, with an exercise price of $0.75. This move is part of the company’s strategic financial operations, potentially impacting its market positioning and offering new opportunities for stakeholders.
The most recent analyst rating on (AU:4DX) stock is a Buy with a A$1.05 price target. To see the full list of analyst forecasts on 4DMedical Ltd stock, see the AU:4DX Stock Forecast page.
More about 4DMedical Ltd
4DMedical Ltd operates in the medical technology industry, specializing in advanced respiratory imaging solutions. The company focuses on developing innovative medical imaging products to enhance the diagnosis and treatment of lung diseases.
Average Trading Volume: 2,185,322
Technical Sentiment Signal: Buy
Current Market Cap: A$360.8M
For detailed information about 4DX stock, go to TipRanks’ Stock Analysis page.